Ms. Ann Therese Kearney, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Golden Oak Dr, Portola Valley, CA 94028 Phone: 650-736-0469 |
News Archive
AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.
A leading industrial illness lawyer has won justice for the family of a man who died after being exposed to asbestos whilst working at the Sellafield nuclear plant.
Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced that it has closed a $35 million Series B round of venture financing, with new investors Johnson & Johnson Development Corporation (JJDC), Skyline Ventures and MP Healthcare Venture Management, Inc. (MPH) joining existing investors Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures.
...including being less likely to be hired, being offered lower salaries and facing a perception that they would be less committed to a job than fathers or women without children, according to an experiment conducted by researchers at Cornell University.
Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke.
› Verified 5 days ago